AstraZeneca has opened its first U.S.-operated cell therapy manufacturing plant in Rockville, Maryland, as part of its ...

The company removed experimental drugs for Alzheimer’s, migraine and pain from its pipeline to focus more resources on “core ...

A new commercial for AstraZeneca’s Truqap constructs a vision of the extra time that the AKT inhibitor can unlock for some ...

Q1 2025 Earnings Call Transcript April 29, 2025 AstraZeneca PLC beats earnings expectations. Reported EPS is $1.3, ...

Albert Bourla said Pfizer is being "frugal" with investments because of the uncertainty surrounding tariffs.

INDIANAPOLIS -- Pascal Siakam posted 24 points and 10 rebounds to help the Pacers escape with a 104-98 win over the Wizards at Gainbridge Fieldhouse on Tuesday night. The Pacers have won five ...

AstraZeneca has come up short in another phase 3 trial of the AKT inhibitor Truqap, raising more questions about the ...

AstraZeneca ( AZN) CEO Pascal Soriot is not overly concerned about the threat of tariffs by the Trump administration on ...

Soriot discussed the impact of potential tariffs during a call on AstraZeneca's earnings. For the three months ended March 31, during which period the firm netted $13.59 billion in total revenue, an ...

Discover AstraZeneca's Q1 2025 performance with 10% revenue growth, innovative medicines, and bold 2030 goals.

Following the recent discontinuations of assets in Alzheimer’s and migraine, AstraZeneca is stepping away from neuro ...